Min Li

Title: Min Li - Innovator in Radionuclide Chemistry

Introduction

Min Li is a prominent inventor based in Davis, California. He has made significant contributions to the field of radionuclide chemistry, particularly in the development of chelating agents that are crucial for medical applications. His innovative work has led to the creation of a patented method that enhances the efficacy of radionuclide-labeled complexes used in medical diagnosis and therapy.

Latest Patents

Min Li holds a patent for a "Method for preparing radionuclide-labeled chelating agent-ligand." This patent describes a process for preparing radionuclide-labeled chelating agent-ligand complexes that are useful in medical diagnosis or therapy. The method involves reacting a radionuclide, such as ⁹⁰Y or ¹¹¹In, with a polyfunctional chelating agent to form a radionuclide chelate that is electrically neutral. The chelate is then purified through anion exchange chromatography and reacted with a targeting molecule, such as a monoclonal antibody, to form the complex.

Career Highlights

Min Li is affiliated with the University of California, where he conducts research and develops innovative solutions in the field of radionuclide chemistry. His work has not only advanced scientific understanding but has also paved the way for new therapeutic approaches in medicine.

Collaborations

Min Li has collaborated with notable colleagues, including Claude F. Meares and Sally Joan Denardo. These collaborations have enriched his research and contributed to the advancement of radionuclide applications in medical science.

Conclusion

Min Li's contributions to radionuclide chemistry exemplify the impact of innovative thinking in the medical field. His patented methods and collaborative efforts continue to influence the development of effective diagnostic and therapeutic agents.